UnitedHealth Group's stock has plunged nearly 50% due to the CEO resignation, withdrawal of guidance, and ongoing legal issues, creating a potential buying opportunity. The stock is deeply oversold with an RSI of 15,

UnitedHealth Group shares rebounded modestly Wednesday following yesterday's crash, with analysts from UBS, Oppenheimer, and Morgan Stanley leaving their ratings unchanged after the health insurer pulled its outlook and announced its CEO had stepped down.

Even UnitedHealth will struggle to overcome parasitic medical costs that Warren Buffett once called a tapeworm eating away at U.S. economic competitiveness. The $300 billion healthcare conglomerate reinstalled Chairman Stephen Hemsley as CEO and yanked its financial guidance.

Nvidia and AMD extend gains after the chip makers sign deals with Saudi Arabia, shares of Super Micro Computer surge for a second day, and UnitedHealth claws back some losses from the previous session.

UnitedHealth Group Incorporated's stock faces a steep decline amid leadership turmoil, regulatory pressures, and rising costs. Click to read why UNH is a Hold.

UnitedHealth Group CEO Andrew Witty has stepped down unexpectedly and company veteran Stephen Hemsley is returning to the top role to steer the healthcare conglomerate through one of its most challenging periods.

The White House unveiled what it says is $600bn worth of defence and artificial intelligence deals with Saudi Arabia, UnitedHealth Group shares sink to the lowest level in more than four years, and US inflation fell to 2.3 per cent in April. Plus, Nissan plans to axe 15 per cent of its global workforce and almost halve its number of plants.

Wall Street is wary of UnitedHealth Group's (UNH) near-term prospects after the company's sudden CEO shake-up and its pulling of 2025 financial guidance on Tuesday. Bank of America Securities, for one,